Table of Contents

Click here to learn more about ZXData

Executive Summary

ZX Market Snapshot: October 2022:

  • SpaceX, Databricks and Stripe were the three most active companies on ZX in October.
  • Bids represented 31% of submitted tickets on ZX in October, a meaningful increase from May 2022's low of 17% but largely consistent with the previous three months of data.

ZXData Reported Holdings: Three months ending August 31st, 2022

  • This quarter reporting holders marked down their private portfolios 3.9% with an average mark-down of 0.5%. The period saw a 1:1 Advance/Decline ratio.
  • Sentiment up:
  • Sentiment down:

Heat Map: August 31st, 2022 Reporting Period

-3.9%

Appreciation/Depreciation of All Reported Holdings1

-0.5%

Average Mark-Up/Mark-Down Across All Reported Holdings2
Korro Bio
24.8%
LifeMine
24.8%
Algolia
24.7%
Castle Creek
24.6%
Dianthus
24.6%
dMed
24.6%
Dragonfly Therapeutics
24.6%
SalioGen
24.6%
Quell
24.5%
Faraday Pharma
24.3%
PrognomIQ
23.6%
FlixBus
22.1%
Boundless Bio
21.3%
Generate Bio
20.6%
Laronde
20.6%
Deep Genomics
20.5%
Evozyne
20.5%
Treeline Bio
20.5%
ValenzaBio
20.5%
Wugen
20.5%
Ankyra
20.4%
Bright Peak
20.4%
Skyhawk
20.4%
T-Knife
20.4%
Sonoma Bio
20.0%
goPuff
19.8%
Blink Health
18.3%
Databricks
17.2%
Asimov
12.5%
Rad Power
11.7%
Diamond Foundry
11.0%
Scorpion Therapeutics
8.2%
Farmers Business Network
7.7%
AgBiome
7.5%
Bytedance
7.2%
Dataminr
6.7%
Reddit
6.6%
Ant Financial
5.7%
Relativity Space
5.3%
Adimab
5.1%
Tempus Labs
4.4%
Fanatics
3.4%
PsiQuantum
1.8%
Freenome
1.2%
Circle
1.1%
Tipalti
0.7%
A24 Films
0.0%
Aledade
0.0%
Alif Semi
0.0%
Arctic Wolf
0.0%
Astera Labs
0.0%
BETA Technologies
0.0%
Canva
0.0%
Caris
0.0%
Cava
0.0%
Celonis
0.0%
Color Genomics
0.0%
Conformal Medical
0.0%
D2iQ
0.0%
Druva
0.0%
Element Bio
0.0%
ElevateBio
0.0%
Enevate
0.0%
Fabletics
0.0%
FLEXE
0.0%
GaN Systems
0.0%
Grammarly
0.0%
GupShup
0.0%
HaulHub
0.0%
Heal
0.0%
Inscripta
0.0%
Insitro
0.0%
Intarcia Therapeutics
0.0%
Kardium
0.0%
Magic Leap
0.0%
MasterClass
0.0%
Menlo Micro
0.0%
Nuro
0.0%
Rappi
0.0%
RefleXion Medical
0.0%
Saluda Medical
0.0%
Savage X
0.0%
Sila Nano
0.0%
SiMa ai
0.0%
SpaceX
0.0%
Tarana
0.0%
Tenstorrent
0.0%
Verily
0.0%
VideoAmp
0.0%
Xsight Labs
0.0%
Resilience
-0.1%
Galvanize
-1.2%
Checkr
-2.0%
Skyryse
-2.1%
MOD Pizza
-2.5%
Waymo
-2.6%
Meesho
-2.7%
DNA Script
-4.2%
Pine Labs
-4.6%
Lime
-4.8%
Unqork
-5.7%
SambaNova
-5.8%
ABL Space
-7.6%
Starling Bank
-7.8%
Aristea Therapeutics
-7.9%
Honor Tech
-8.6%
Stripe
-9.2%
Epic Games
-10.6%
CelLink
-10.9%
Tory Burch
-11.7%
Bowery
-14.0%
BYJU's
-16.8%
Seismic
-17.0%
Redwood Materials
-25.2%
Chime
-26.8%
Discord
-27.0%
Signifyd
-27.1%
Rapyd
-28.2%
Thriveworks
-28.3%
Convoy
-29.7%
ServiceTitan
-30.0%
Instacart
-30.2%
Airtable
-30.3%
Goop
-30.7%
MNTN
-32.0%
Bolt
-37.1%
Bolt Threads
-38.5%
Bombas
-43.2%
Astranis
-53.0%
Omada Health
-54.0%
JUUL
-77.9%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

Analysis

Positive Trend Reversal3 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal4 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal3 (# = consecutive prior qtrs marked down or flat)
Ant Financial
7
Dragonfly Therapeutics
7
Castle Creek, dMed
5
Faraday Pharma, Scorpion Therapeutics
5
Negative Trend Reversal4 (# = consecutive prior qtrs marked up or flat)
Goop
8
Waymo
8
Bombas
5
Resilience
5

3 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
4 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

Highest Variance in Reported Marks5
CompanyNormalized Std Dev5$ Weighted AvgMaxMin
Redwood Materials.20$36.07$52.15$32.85
PsiQuantum.13$23.89$27.02$20.58
Epic Games.12$831.53$930.03$734.17
Scorpion Therapeutics.11$1.09$1.25$1.00
Grammarly.10$22.21$26.21$20.97

5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

ZX Marketed Bids at Greatest Premium to Latest Reported Median Holding Value6
There were no marketed bids at a premium to August median holding values
ZX Marketed Offers at Greatest Discount to Latest Reported Median Holding Value6
BYJU’s
-60.7%
Circle
-34.3%
Epic Games
-22.0%
Celonis
-20.2%

6 Premium and Discount agnostic to share class

ZX Market Snapshot: October 2022

Most Active Companies7

1
SpaceX
2
arrow up
Databricks
3
arrow down
Stripe
4
arrow up
Attentive
5
Flexport
6
arrow down
Klarna
7
arrow down
Epic Games
8
arrow up
FTX Exchange
9
arrow up
Deel
10
arrow down
Discord

7 Companies that received the most ticket and profile view activity over the last 30 days

SpaceX, Databricks and Stripe were the three most active companies on ZX in October.

Bids represented 31% of submitted tickets on ZX in October, a meaningful increase from May 2022's low of 17% but largely consistent with the previous three months of data.

On average, ZX Sell Orders sit at a 20.8% discount to August’s median holding values, highlighted by offers in BYJU's and Circle. There were no bids at a premium to median holding values in October.

ZXData Reported Holdings Commentary: Three months ending August 31st, 2022

This quarter, reporting holders marked down their private portfolios 3.9% with an average mark-down of 0.5%. The period saw one company decline for each advancing company.

LifeMine and Korro Bio saw the largest mark-up this reporting period, with Algolia, SalioGen, Dragonfly Therapeutics, dMed, Dianthus and Castle Creek rounding out the largest gainers. Software saw the largest appreciation across sectors. JUUL saw the largest mark-down this reporting period, with Omada Health, Astranis and Bombas rounding out the largest decliners. Logistics saw the largest depreciation across sectors.

Ant Financial and Dragonfly Therapeutics saw their first positive reversals in seven quarters while Castle Creek, dMed, Faraday Pharma and Scorpion Therapeutics saw their first positive reversals in five quarters. Goop and Waymo saw their first negative reversals in two years, while Bombas and Resilience saw their first negative reversals in five quarters.

This period, Redwood Materials ($32.85 - $52.15) saw the highest share price variance across funds.

Disclaimer

This report is based on data reported by 250+ funds and $40 billion+ of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for factual information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report may not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right